Secular trends in pediatric antiretroviral treatment programs in rural and urban Zambia: A retrospective cohort study

BMC Pediatrics

Volumn 10, Issue , 2010, Pages

  Sutcliffe, Catherine G ^a   Bolton Moore, Carolyn ^b   van Dijk, Janneke H ^c   Cotham, Matt ^d   Tambatamba, Bushimbwa ^e   Moss, William J ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^c Macha Hospital   (Zambia)

^d Mukinge Hospital   (Zambia)

^e MINISTRY OF HEALTH   (Zambia)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR PLUS LAMIVUDINE; EFAVIRENZ; NEVIRAPINE; STAVUDINE; ZIDOVUDINE; ANTIRETROVIRUS AGENT;

ARTICLE; CHILD; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RURAL AREA; SCHOOL CHILD; TREATMENT OUTCOME; URBAN AREA; ZAMBIA; COHORT ANALYSIS; HEALTH SERVICE; INFANT; RURAL HEALTH CARE;

ANTI-RETROVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INFANT; MALE; RURAL HEALTH SERVICES; TREATMENT OUTCOME; URBAN HEALTH SERVICES; ZAMBIA;

EID: 77955067914     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-10-54     Document Type: Article

References (28)

1. The 3 by 5 Initiative. , http://www.who.int/3by5/en/
2. WHO Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2009. 2009, Geneva, Switzerland: World Health Organization, WHO.
3. Sutcliffe CG, van Dijk JH, Bolton C, Persaud D, Moss WJ. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. The Lancet infectious diseases 2008, 8:477-489. 10.1016/S1473-3099(08)70180-4, 18652994.
4. De Baets AJ, Ramet J, Msellati P, Lepage P. The unique features of pediatric HIV-1 in sub-Saharan Africa. Current HIV research 2008, 6:351-362. 10.2174/157016208785132491, 18691033.
5. Keiser O, Anastos K, Schechter M, Balestre E, Myer L, Boulle A, Bangsberg D, Toure H, Braitstein P, Sprinz E, et al. Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Trop Med Int Health 2008, 13:870-879.
6. Bekker LG, Myer L, Orrell C, Lawn S, Wood R. Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa. South African medical journal 2006, 96:315-320.
7. Boulle A, Bock P, Osler M, Cohen K, Channing L, Hilderbrand K, Mothibi E, Zweigenthal V, Slingers N, Cloete K, et al. Antiretroviral therapy and early mortality in South Africa. Bulletin of the World Health Organization 2008, 86:678-687. 10.2471/BLT.07.045294, 2649489, 18797643.
8. Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, Schechter M, Laurent C, Keiser O, May M, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bulletin of the World Health Organization 2008, 86:559-567. 10.2471/BLT.07.044248, 2647487, 18670668.
9. WHO Taking Stock: Health worker shortages and the response to AIDS. 2006, Geneva, Switzerland: World Health Organization, WHO.
10. WHO Towards Universal Access: Scaling up Priority HIV/AIDS Interventions in the Health Sector. Progress Report 2008. 2008, Geneva, Switzerland: World Health Organization, WHO.
11. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM, Chi BH, Sinkala M, Kankasa C, Wilson CM, Wilfert CM, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA 2007, 298:1888-1899. 10.1001/jama.298.16.1888, 17954540.
12. Van Dijk JH, Sutcliffe CG, Munsanje B, Hamangaba F, Thuma PE, Moss WJ. Barriers to the care of HIV-infected children in rural Zambia: a cross-sectional study. BMC infectious diseases 2009, 9:169. 10.1186/1471-2334-9-169, 2767351, 19835604.
13. Carlucci JG, Kamanga A, Sheneberger R, Shepherd BE, Jenkins CA, Spurrier J, Vermund SH. Predictors of adherence to antiretroviral therapy in rural Zambia. Journal of acquired immune deficiency syndromes 2008, 47:615-622. 10.1097/QAI.0b013e318165dc25, 2743102, 18209678.
14. Census 2000. , http://www.zamstats.gov.zm/census.php
15. WHO Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach, 2003 revision. 2004, Geneva: WHO, WHO.
16. WHO Antiretroviral therapy of HIV infection in infants and children: Towards universal access. Recommendations for a public health approach. 2006, Geneva, Switzerland: World Health Organization, WHO.
17. The WHO Child Growth Standards. , http://www.who.int/childgrowth/en/
18. The KIDS-ART-LINC Collaboration Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa. Journal of acquired immune deficiency syndromes 2008, 49:523-531. 10.1097/QAI.0b013e31818aadce, 18989227, The KIDS-ART-LINC Collaboration.
19. Ford N, Mills E, Calmy A. Rationing antiretroviral therapy in Africa--treating too few, too late. The New England journal of medicine 2009, 360:1808-1810. 10.1056/NEJMp0902820, 19403900.
20. Rosen S, Ketlhapile M, Sanne I, Desilva MB. Characteristics of Patients Accessing Care and Treatment for HIV/AIDS at Public and Nongovernmental Sites in South Africa. J Int Assoc Physicians AIDS Care 2008, 7:200-207.
21. Rosen S, Long L, Sanne I. The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa. Trop Med Int Health 2008, 13:1005-1015. 10.1111/j.1365-3156.2008.02114.x, 18631314.
22. Chi BH, Chintu N, Lee A, Stringer EM, Sinkala M, Stringer JS. Expanded services for the prevention of mother-to-child HIV transmission: field acceptability of a pilot program in Lusaka, Zambia. Journal of acquired immune deficiency syndromes 2007, 45:125-127. 10.1097/QAI.0b013e318050d28f, 17460478.
23. WHO Antiretroviral therapy for HIV infection in infants and children: Towards universal access. Executive summary of recommendations. 2010, Geneva, Switzerland: World Heatlh Organization, WHO.
24. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, Jean-Philippe P, McIntyre JA. Early antiretroviral therapy and mortality among HIV-infected infants. The New England journal of medicine 2008, 359:2233-2244. 10.1056/NEJMoa0800971, 19020325.
25. Dalal RP, Macphail C, Mqhayi M, Wing J, Feldman C, Chersich MF, Venter WD. Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in johannesburg, South Africa. Journal of acquired immune deficiency syndromes 2008, 47:101-107. 10.1097/QAI.0b013e31815b833a, 17971708.
26. Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PloS one 2009, 4:e5790. 10.1371/journal.pone.0005790, 2686174, 19495419.
27. Krebs DW, Chi BH, Mulenga Y, Morris M, Cantrell RA, Mulenga L, Levy J, Sinkala M, Stringer JS. Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. AIDS care 2008, 20:311-317. 10.1080/09540120701594776, 18351478.
28. Sutcliffe CG, Van Dijk JH, Bolton C, Cotham M, Tambatamba B, Moss WJ. Differences in presentation, treatment initiation and response among children infected with human immunodeficiency virus in urban and rural Zambia. The Pediatric infectious disease journal 2010, 29.